Brief: Gt Biopharma Inc - On February 22, 2023, Co Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq

GT Biopharma

28/02/2023 22:22

Feb 28 (Reuters) - GT Biopharma Inc  GTBP.O :
    * GT BIOPHARMA INC - ON FEBRUARY 22, 2023, CO RECEIVED
NOTICE OF
DELISTING OR FAILURE TO SATISFY A CONTINUED LISTING RULE OR
STANDARD FROM NASDAQ

Further company coverage:  GTBP.O 

 ((Reuters.Briefs@thomsonreuters.com;;))